Eqis Capital Management, Inc. Charles River Laboratories International, Inc. Transaction History

Eqis Capital Management, Inc.

$1.17 Billion
Q2 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$203.52 - $273.43 $69,807 - $93,786	-343 Reduced 29.88%	805 $218,000
Q4 2023 Feb 14, 2024	SELL	$164.52 - $238.84 $44,255 - $64,247	-269 Reduced 18.98%	1,148 $271,000
Q3 2023 Nov 13, 2023	BUY	$194.44 - $217.61 $777 - $870	4 Added 0.28%	1,417 $277,000
Q2 2023 Aug 14, 2023	SELL	$183.71 - $210.25 $65,768 - $75,269	-358 Reduced 20.21%	1,413 $297,000
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $110,144 - $149,194	574 Added 47.95%	1,771 $357,000
Q4 2022 Feb 14, 2023	SELL	$197.11 - $250.07 $4,927 - $6,251	-25 Reduced 2.05%	1,197 $260,000
Q3 2022 Oct 24, 2022	SELL	$182.44 - $250.54 $7,115 - $9,771	-39 Reduced 3.09%	1,222 $240,000
Q2 2022 Aug 08, 2022	BUY	$204.13 - $302.4 $1,428 - $2,116	7 Added 0.56%	1,261 $269,000
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $173,235 - $245,510	-678 Reduced 35.09%	1,254 $356,000
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $20,380 - $26,023	58 Added 3.09%	1,932 $728,000
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $72,664 - $89,368	-195 Reduced 9.42%	1,874 $773,000
Q2 2021 Aug 12, 2021	SELL	$294.17 - $371.65 $32,064 - $40,509	-109 Reduced 5.0%	2,069 $765,000
Q1 2021 May 14, 2021	SELL	$249.67 - $299.48 $148,553 - $178,190	-595 Reduced 21.46%	2,178 $631,000
Q4 2020 Feb 11, 2021	SELL	$222.0 - $252.62 $66,600 - $75,786	-300 Reduced 9.76%	2,773 $693,000
Q3 2020 Nov 10, 2020	SELL	$175.56 - $226.45 $105,336 - $135,870	-600 Reduced 16.34%	3,073 $696,000
Q2 2020 Aug 10, 2020	SELL	$118.84 - $189.72 $138,567 - $221,213	-1,166 Reduced 24.1%	3,673 $640,000
Q1 2020 May 12, 2020	BUY	$98.9 - $178.34 $161,207 - $290,694	1,630 Added 50.79%	4,839 $755,000
Q4 2019 Jan 24, 2020	SELL	$126.05 - $152.76 $268,486 - $325,378	-2,130 Reduced 39.9%	3,209 $490,000
Q3 2019 Nov 05, 2019	BUY	$125.07 - $143.67 $181,101 - $208,034	1,448 Added 37.21%	5,339 $707,000
Q2 2019 Jul 18, 2019	SELL	$123.4 - $148.55 $304,427 - $366,472	-2,467 Reduced 38.8%	3,891 $552,000
Q1 2019 Apr 18, 2019	SELL	$104.82 - $146.73 $83,751 - $117,237	-799 Reduced 11.16%	6,358 $923,000
Q4 2018 Jan 25, 2019	BUY	$105.09 - $137.23 $168,984 - $220,665	1,608 Added 28.98%	7,157 $810,000
Q3 2018 Oct 17, 2018	BUY	$112.11 - $134.54 $18,946 - $22,737	169 Added 3.14%	5,549 $692,000
Q2 2018 Jul 27, 2018	BUY	$102.37 - $117.25 $550,750 - $630,805	5,380 New	5,380 $604,000
Q4 2017 Jan 25, 2018	SELL	$100.43 - $118.09 $425,622 - $500,465	-4,238 Closed	0 $0
Q3 2017 Oct 03, 2017	BUY	$96.72 - $109.26 $409,899 - $463,043	4,238	4,238 $458,000

Others Institutions Holding CRL

# of Institutions

730

Shares Held

51.8M

Call Options Held

233K

Put Options Held

236K

Vanguard Group Inc Valley Forge, PA

6.1M
Shares

$1.16 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$971 Million
0.02% of portfolio
State Street Corp Boston, MA

2.09M
Shares

$399 Million
0.02% of portfolio
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA

1.91M
Shares

$364 Million
0.99% of portfolio
Clearbridge Investments, LLC New York, NY

1.37M
Shares

$261 Million
0.24% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.7B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.

Account